FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

No Committee for Aquestives Anaphylm

[ Price : $8.95]

FDA says an advisory committee is not needed to discuss the Aquestive NDA for Anaphylm to treat severe allergic reactions.

FDA Pledges Prompt CRL Release

[ Price : $8.95]

FDA releases 89 previously unpublished complete response letters and says future letters will be released immediately after transm...

Medtronic Recalls DLP Left Heart Vent Catheters

[ Price : $8.95]

Medtronic Perfusion Systems recalls (Class 1) its DLP Left Heart Vent Catheters (malleable body and vented connector) because the ...

FDA Posts Alopecia Complex Case Study

[ Price : $8.95]

FDA posts a drug complex innovative design case study for a higher dose of an alopecia areata drug that did not assign participant...

CGMP Violations at Amneal Gujarat, India

[ Price : $8.95]

FDA warns Amneal Pharmaceuticals about CGMP violations in its Gujarat, India, drug manufacturing facility.

FDA, CDC Staff Pen Open Letter to Remove RFK Jr.

[ Price : $8.95]

Over a thousand current and former staff at FDA, CDC, and NIH pen a new open letter to HHS secretary Robert F. Kennedy Jr. and Con...

Prasad Has Covid YouTube Videos Pulled

[ Price : $8.95]

The Guardian says CBER director Vinay Prasad successfully had videos of him criticizing Covid vaccines removed from the YouTube ch...

Boehringer Gets Breakthrough Status for Hernexeos

[ Price : $8.95]

FDA grants Boehringer Ingelheim a breakthrough therapy designation for Hernexeos (zongertinib) tablets for the first-line treatmen...

FDA Rare Disease Evidence Principles

[ Price : $8.95]

CDER and CBER launch the Rare Disease Evidence Principles process intended to bring greater speed and predictability to the review...

CBER Raising Bar on Future Covid Vaccines

[ Price : $8.95]

Memos posted on FDAs Web site from CBER director Vinay Prasad suggest the agency is raising the bar on future Covid-19 vaccination...